人肝CD69+CD103-CD8+T细胞功能依赖HIF-2α活性
研究比较健康供者和肝硬化受者肝灌注液及配对外周血,以及急性甲型肝炎患者肝组织,发现人肝CD69+CD103-CD8+T细胞呈组织驻留和终末分化表型,其效应功能和存活依赖HIF-2α,且在急性甲型肝炎或肝硬化中HIF-2α表达显著增加。
要点
- 肝CD69+CD103-CD8+T细胞呈组织驻留、终末分化表型,表达HIF-2α。
- 该细胞群效应功能与存活依赖HIF-2α,抑制HIF-2α可削弱其功能。
- 急性甲型肝炎或肝硬化中该细胞HIF-2α表达显著增高。
核心结论
- 肝CD69+CD103-CD8+T细胞是组织驻留终末分化细胞,其效应功能依赖HIF-2α。
- 肝病病理状态下该细胞活化并上调HIF-2α,提示参与肝内免疫应答和疾病发病。
研究设计与样本
- 收集健康活体供者和肝硬化受者肝移植时的肝灌注液及配对外周血,以及急性甲型肝炎患者肝组织。
- 用流式细胞术进行表型和功能分析,用微阵列和定量逆转录PCR测定基因表达谱。
- 使用PT-2385抑制HIF-2α。
主要发现
- 人肝CD69+CD8+T细胞约95%为CD103-、约5%为CD103+。
- CD69+CD103-CD8+T细胞呈组织驻留和终末分化表型并上调HIF-2α。
- CD103-细胞包含非嗜肝病毒特异性和嗜肝病毒特异性T细胞,而CD103+细胞仅显示嗜肝病毒特异性。
- CD103-细胞单细胞效应弱于CD103+细胞,但经T细胞受体或白介素-15刺激后仍是肝内主要CD69+CD8+效应群体,且细胞死亡较少。
- HIF-2α抑制剂抑制CD69+CD103-CD8+T细胞的效应功能和存活。
临床怎么用
- 肝内CD69+CD103-CD8+T细胞的功能评估可关注HIF-2α表达水平。
- HIF-2α抑制剂可抑制该细胞群效应功能与存活,提示潜在免疫干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Human liver CD69+CD8+ T cells are ~95% CD103- and ~5% CD103+. Although CD69+CD103+CD8+ T cells show tissue residency and robustly respond to antigens, CD69+CD103-CD8+ T cells are not yet well understood. METHODS: Liver perfusate and paired peripheral blood were collected from healthy living donors and recipients with cirrhosis during liver transplantation. Liver tissues were obtained from patients with acute hepatitis A. Phenotypic and functional analyses were performed by flow cytometry. Gene expression profiles were determined by microarray and quantitative reverse transcription PCR. PT-2385 was used to inhibit hypoxia-inducible factor (HIF)-2α. RESULTS: Human liver CD69+CD103-CD8+ T cells exhibited HIF-2α upregulation with a phenotype of tissue residency and terminal differentiation. CD103- cells comprised non-hepatotropic virus-specific T cells as well as hepatotropic virus-specific T cells, but CD103+ cells exhibited only hepatotropic virus specificity. Although CD103- cells were weaker effectors on a per cell basis than CD103+ cells, following T cell receptor or interleukin-15 stimulation, they remained the major CD69+CD8+ effector population in the liver, surviving with less cell death. An HIF-2α inhibitor suppressed the effector functions and survival of CD69+CD103-CD8+ T cells. In addition, HIF-2α expression in liver CD69+CD103-CD8+ T cells was significantly increased in patients with acute hepatitis A or cirrhosis. CONCLUSIONS: Liver CD69+CD103-CD8+ T cells are tissue resident and terminally differentiated, and their effector functions depend on HIF-2α. Furthermore, activation of liver CD69+CD103-CD8+ T cells with HIF-2α upregulation is observed during liver pathology. LAY SUMMARY: The immunologic characteristics and the role of CD69+CD103-CD8+ T cells, which are a major population of human liver CD8+ T cells, remain unknown. Our study shows that these T cells have a terminally differentiated tissue-resident phenotype, and their effector functions depend on a transcription factor, HIF-2α. Furthermore, these T cells were activated and expressed higher levels of HIF-2α in liver pathologies, suggesting that they play an important role in immune responses in liver tissues and the pathogenesis of human liver disease.
引用
- Kim JH, Han JW, Choi YJ, et al. Functions of human liver CD69+CD103-CD8+ T cells depend on HIF-2α activity in healthy and pathologic livers. J Hepatol. 2020. PMID: 31987989. doi:10.1016/j.jhep.2020.01.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。